Status:
COMPLETED
Reduction of the Glycemic Index by a Novel Viscous Polysaccharide
Lead Sponsor:
Glycemic Index Laboratories, Inc
Collaborating Sponsors:
InovoBiologic Inc.
Canadian Center for Functional Medicine
Conditions:
Blood Glucose, Postprandial
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
PHASE3
Brief Summary
Reductions of postprandial glucose levels have been demonstrated previously with the addition of a novel viscous polysaccharide (NVP) to a glucose drink and standard white bread. This study explores w...
Detailed Description
Recently, a commercial novel viscous polysaccharide (NVP)complex has been developed which is marketed in both the USA and Canada under the trade name PGX® (PolyGlycopleX) (InovoBiologic Inc, Calgary, ...
Eligibility Criteria
Inclusion
- healthy individuals
- 18-75 years old
- BMI less than 35 kg/m2
Exclusion
- Medications influencing gastrointestinal function
- Pregnancy
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2006
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00935350
Start Date
May 1 2006
End Date
August 1 2006
Last Update
July 9 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Glycemic Index Laboratories, Inc.
Toronto, Ontario, Canada